CompuGroup stock enters an AI reset with EUR 1,246.81 million revenue

Published on 10/08/2026 at 09:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CompuGroup stock enters an AI-led transformation after a Signify Research review dated October 6, 2026. Fiscal 2025 revenue reached EUR 1,246.81 million.

Aquarell-Panorama Koblenz mit Festung Ehrenbreitstein, Rhein und Mosel — CompuGroup Medical hat seinen Hauptsitz in Koblenz, hier als Aquarell-Stadtpanorama an Rhein und Mosel, DE000A288904, Illustration mit AI erstellt.

CompuGroup Medical (ISIN DE000A288904) reported fiscal year 2025 revenue of EUR 1,246.81 million, while its net income fell 18.37 percent to EUR 28.24 million. A Signify Research review dated October 6, 2026, frames the companys cloud and artificial intelligence transformation as a test of software reliability and customer trust.

Revenue grows while profit contracts

Investing.com lists fiscal year 2025 revenue at EUR 1,246.81 million and net income at EUR 28.24 million. The same annual statement shows EBITDA of EUR 133.26 million, down 9.26 percent, and an EBITDA margin of 10.69 percent.

The contrast matters for the transformation. Revenue increased 5.1 percent in the annual comparison shown by the financial statement, but operating income declined 10.4 percent to EUR 87.74 million and diluted earnings per share fell 18.18 percent to EUR 0.54.

Cloud strategy meets customer pressure

Signify Research says CompuGroup is modernizing its healthcare software through cloud infrastructure, connected platforms, artificial intelligence and data services. The research identifies the ambulatory information systems business as the pressure point, with organic growth of 1 percent in 2025 compared with 10 percent for hospital systems and 7 percent for pharmacy systems.

The companys operating model spans practice management, electronic medical records, hospital administration and pharmacy software. That installed base gives the transformation scale, but the customer experience must improve for the investment program to translate into stronger growth.

Research spending raises the execution bar

CompuGroup spent EUR 274.1 million on research and development in 2025, up from EUR 255.1 million in 2024, according to Signify Research. The review also reports adjusted EBITDA of EUR 240.2 million and free cash flow of EUR 87.7 million for 2025, showing why the distinction between reported and adjusted profitability matters.

The next financial checkpoint is scheduled for November 5, 2026, when CompuGroup is set to publish its next earnings report, according to Investing.com.

Next earnings date sets checkpoint

CompuGroup stock now has a measurable test ahead: fiscal year 2025 revenue growth must be matched by better operating leverage and stronger customer acceptance of the cloud transition.